Learn About Cancer Clinical Trials
Who Conducts and Sponsors Cancer Clinical Trials?
Cancer clinical trials are conducted by dedicated researchers in
a variety of settings throughout the United States—from teaching universities
and cancer centers—to individual practices and community hospitals. Sponsors
include various organizations in both government and industry. Here is a brief
look at some of the major sponsors of cancer clinical trials.
There are 10 major cancer cooperative
groups in the United States and Canada. These regional and national groups are
networks of institutions and investigators at academic hospitals, community
hospitals, and medical practices that voluntarily collaborate to conduct cancer
research. About half the cancer patients participating in cancer clinical trials in
any given year are part of cooperative group studies.
Sixty institutions have been designated
as Comprehensive or Clinical Cancer Centers by the National Cancer Institute
(NCI). These centers conduct several hundred cancer clinical trials in any given year.
Community Clinical Oncology Program (CCOP)
This network makes cancer clinical trials
accessible to patients in smaller communities in 29 states. It includes
community cancer specialists and primary care physicians.
Although most government-sponsored
cancer clinical trials are conducted through the NCI, several other agencies
conduct or sponsor cancer-related clinical research. These include the National
Heart, Lung and Blood Institute, National Institute of Neurological Disorders
and Stroke, the Department of Defense, and the Department of Veteran’s Affairs.
More than 100 pharmaceutical companies
conduct cancer clinical trials, many involving early-phase research.